Reducing Hospital Readmissions Doesn't Up Mortality Rates

Share this content:
Reducing Hospital Readmissions Doesn't Up Mortality Rates
Reducing Hospital Readmissions Doesn't Up Mortality Rates

WEDNESDAY, July 19, 2017 (HealthDay News) -- Reducing hospital readmission rates for acute myocardial infarction, heart failure, and pneumonia didn't increase mortality rates, according to a study published in the July 18 issue of the Journal of the American Medical Association.

As part of the Affordable Care Act, U.S. hospitals face significant financial penalties if they have too many readmissions. Since enactment of the health care law, readmission rates within 30 days after patient discharge have been significantly reduced. To find out how that might affect mortality rates, researchers analyzed data on Medicare patients hospitalized for acute myocardial infarction, heart failure, or pneumonia between 2008 and 2014.

Reductions in readmissions among these patients did not lead to higher mortality rates, and may even have lowered death rates, according to the researchers. One reason might be that hospitals have taken steps to improve in-hospital and after-hospital care. Such measures include better preparing patients and families for discharge, more timely follow-up, and improved communication with outpatient health care providers, the investigators said.

"Our study validates that the national focus on readmissions improved outcomes without causing unintended harm," senior author Harlan Krumholz, M.D., a professor of cardiology at Yale University in New Haven, Conn., said in a university news release. "Thousands and thousands of readmissions are being avoided every year without any evidence of people being harmed. That is a victory of improving the quality of care."

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »